financetom
Business
financetom
/
Business
/
W.W. Grainger's Q3 Earnings, Net Sales Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
W.W. Grainger's Q3 Earnings, Net Sales Rise
Oct 31, 2024 6:26 AM

08:51 AM EDT, 10/31/2024 (MT Newswires) -- W.W. Grainger ( GWW ) reported Q3 earnings Thursday of $9.87 per diluted share, up from $9.43 a year earlier.

Analysts polled by Capital IQ expected $9.96.

Net sales for the quarter ended Sept. 30 were $4.39 billion, up from $4.21 billion a year earlier.

Analysts surveyed by Capital IQ expected $4.4 billion.

The company said it now expects 2024 adjusted earnings of $38.65 to $39.35 per diluted share, compared with its prior guidance of $38 to $39.50. Analysts polled by Capital IQ expect $38.70.

Net sales for the year are now expected to be $17.1 billion to $17.3 billion, compared with its earlier expectation of between $17 billion and $17.3 billion. Analysts surveyed by Capital IQ expect $17.19 billion.

Shares of the company were down 1.8% in recent Thursday premarket activity.

Price: 1,080.00, Change: -19.34, Percent Change: -1.76

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pactiv Evergreen Completes $110 Million Sale of Paper Plants to Suzano
Pactiv Evergreen Completes $110 Million Sale of Paper Plants to Suzano
Oct 2, 2024
08:49 AM EDT, 10/01/2024 (MT Newswires) -- Pactiv Evergreen ( PTVE ) said Tuesday it has completed the $110 million sale of its Pine Bluff, Ark., paper mill and Waynesville, N.C., extrusion facility to Brazilian paper producer Suzano. Pactiv President and Chief Executive Michael King said the sale will smooth the company's transition to a capital-light business model and is...
BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell
BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell
Oct 2, 2024
08:46 AM EDT, 10/01/2024 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) said Tuesday that a breast cancer patient treated in a phase 2 study of the company's Bria-IMT regimen showed a dramatic anti-tumor response. The company said treatment with its Bria-IMT regimen resulted in complete resolution of right temporal lobe brain metastasis in the patient with eye-bulging metastatic breast...
Health insurers unveil Medicare Advantage plans for 2025
Health insurers unveil Medicare Advantage plans for 2025
Oct 2, 2024
Oct 1 (Reuters) - Health insurers Cigna ( CI ), CVS Health ( CVS ), Humana and Centene ( CNC ) on Tuesday released details on their government-backed health insurance plans for next year for people aged 65 and above. The announcements come ahead of the beginning of enrollment for Medicare Advantage plans on October 15, which will continue through...
Paychex Fiscal Q1 Adjusted Earnings, Revenue Rise
Paychex Fiscal Q1 Adjusted Earnings, Revenue Rise
Oct 2, 2024
08:46 AM EDT, 10/01/2024 (MT Newswires) -- Paychex ( PAYX ) reported fiscal Q1 adjusted earnings Tuesday of $1.16 per diluted share, up from $1.14 a year earlier. Analysts surveyed by Capital IQ expected $1.14. Revenue for the quarter ended Aug. 31 was $1.32 billion, compared with $1.29 billion a year earlier. Analysts polled by Capital IQ expected $1.31 billion....
Copyright 2023-2026 - www.financetom.com All Rights Reserved